SQ
SQZ Biotechnologies Company
SQZB · OTC
$0.02 +0.00% (+$0.00)
1M +0.00%
Market Cap $707.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.01x
P/S 0.03x
EV/EBITDA N/A
Growth
26 /100
Declining Book val. growth 0.83%
Rev. growth 1.50%
FCF growth N/A
Profitability
19 /100
Weak Net margin 377.88%
Op. margin 383.68%
FCF margin 399.79%
Quality
3 /100
Poor ROA 74.14%
Asset turnover 0.20x
ROIC 81.66%
Debt
91 /100
Low Current ratio 3.12x
Net debt/EBITDA 0.46x
Debt/Equity 0.60x
Stability
44 /100
Moderate Rev. volatility 25.73%
EPS volatility 23.36%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SQZB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Howard Bernstein
Employees
53
Headquarters
Watertown
Evenimente viitoare
12 NOV.
Earnings
Upcoming earnings report